Does TMS Work? An Honest Guide to Response and Remission in Nebraska

Does TMS Work? An Honest Guide to Response and Remission in Nebraska

Transcranial magnetic stimulation (TMS) can help some people with depression, particularly when medication, talking therapy or both have not provided enough relief. It is not a guaranteed treatment, and it does not work in the same way for everyone.

When reading about TMS, it is useful to understand the difference between response and remission. These are clinical terms used in research studies and treatment discussions to describe different levels of improvement. They can help set realistic expectations, but they cannot predict exactly what one person’s experience will be.

TMS Therapy Nebraska lists 11 published clinics across the state, including clinics in Omaha, Lincoln, Fremont, Bellevue, Lexington, Kearney and Blair. Availability may make it easier for some people to explore treatment locally, but a proper clinical assessment remains the starting point.

What is TMS?

TMS is a non-invasive treatment that uses magnetic pulses to stimulate specific areas of the brain involved in mood regulation. During treatment, a clinician places a magnetic coil against the scalp. The patient remains awake and can usually return to normal activities afterwards.

In the United States, TMS received FDA clearance for major depressive disorder in 2008. FDA clearance later included depression with comorbid anxiety in 2021.

A standard TMS course commonly involves around 36 weekday sessions, delivered over roughly six to nine weeks. The exact plan can vary according to the type of TMS used, the treatment protocol, clinical need and the provider’s assessment.

TMS is often considered for adults with depression that has not improved sufficiently with other treatments. It may be used alongside medication and psychotherapy rather than as a replacement for every other form of care.

What does “response” mean?

In TMS studies, a response usually means that a person’s depression symptoms have reduced substantially from where they started. Researchers commonly define response as at least a 50% reduction on a recognised depression rating scale.

This does not necessarily mean that all symptoms have gone away. Someone might still experience low mood, reduced motivation, sleep difficulties or anxiety, but notice that these symptoms are less intense or less frequent. They may find daily activities more manageable, feel more able to engage with family or work, or have fewer days dominated by depression.

Response is meaningful because depression can be disabling even when it is not at its most severe. A substantial reduction in symptoms may improve quality of life and make it easier to benefit from ongoing therapy, medication reviews, healthier routines and social support.

However, response is not the same as a cure. Symptoms can remain, and some people need continued treatment or follow-up care to protect the progress they have made.

What does “remission” mean?

Remission generally means that depression symptoms have improved to a low level, often below a set threshold on a clinical rating scale. In everyday language, remission means that a person is no longer experiencing a clinically significant level of depression, even if they still have occasional difficult days.

Remission is usually considered a stronger outcome than response. A person in remission may feel closer to their usual self, regain interest in activities, sleep and concentrate better, and experience much less disruption from depression.

It is important not to interpret remission as a promise that depression will never return. Depression can be recurrent, and some people who improve with TMS later need further support. This may include medication, psychotherapy, lifestyle support, psychiatric follow-up or, where clinically appropriate, another course of TMS.

For some people, an important treatment outcome may fall between no improvement and full remission. A noticeable reduction in symptoms can still matter greatly, particularly if it improves safety, functioning, relationships or the ability to take part in other treatment.

What do published TMS trials report?

Published clinical trials have found that TMS can lead to response and remission for a meaningful proportion of people with depression, including people whose symptoms have continued despite previous treatment attempts.

At the same time, trial findings should be read carefully. Not every participant responds, and not everyone who responds reaches remission. Different studies can report different results because they may involve different groups of patients, treatment protocols, symptom measures and definitions of improvement.

For example, a trial may differ according to:

• The severity and duration of participants’ depression
• How many previous treatments they had tried
• Whether participants were taking antidepressant medication
• The TMS protocol and number of sessions used
• Whether anxiety, trauma symptoms, substance use or other health conditions were present
• How response and remission were measured

Research results are useful for showing that TMS can work, but they cannot tell an individual patient exactly what will happen. A clinician can discuss how the evidence relates to a person’s own history, symptoms and goals.

Why do individual results vary?

Depression is not one identical condition. Two people may both have a diagnosis of major depressive disorder while having very different symptom patterns, medical histories, life stresses and previous treatment experiences. It follows that their response to TMS may differ as well.

Several factors may influence outcomes. These do not provide a simple prediction, but they are often considered during assessment and follow-up.

Previous treatment history

TMS is frequently considered after other depression treatments have not helped enough. The number and type of previous treatments can vary widely. Someone who has had partial benefit from medication may have a different outlook from someone whose depression has remained severe through several approaches.

Completing the planned course

TMS usually involves regular weekday appointments over several weeks. Attending consistently matters because the treatment effect is built over a course, rather than being expected after one or two sessions.

Practical issues can affect this. Travel, work, family responsibilities, illness and changing circumstances can make frequent appointments difficult. When choosing between Nebraska clinics, it may be helpful to ask about scheduling, missed-session policies and the likely duration of visits.

Other mental and physical health needs

Depression can occur alongside anxiety, trauma-related symptoms, chronic pain, sleep problems, substance use, attention difficulties and physical health conditions. These concerns do not automatically rule out TMS, but they may affect treatment planning and how improvement is measured.

TMS is FDA-cleared for depression with comorbid anxiety, but this does not mean that every anxiety presentation will respond in the same way. A clinician should consider the full picture rather than focusing only on one diagnosis.

Expectations and ongoing support

It is reasonable to hope that TMS may help, while also recognising uncertainty. Some people notice gradual changes in mood, energy or motivation over the course of treatment. Others may not notice a clear change until later, and some may not find TMS beneficial.

TMS is often most useful as part of a wider care plan. Continuing with appropriate therapy, medication management, sleep support and regular clinical review may remain important, whether or not TMS leads to remission.

What should you ask a Nebraska TMS provider?

A consultation is an opportunity to get clear, individualised information. You may wish to ask:

• Why TMS is being recommended in your situation
• What treatment protocol is proposed and how often you would attend
• How the clinic measures progress during treatment
• What would happen if your symptoms do not improve
• Whether medication or therapy should continue during TMS
• Whether maintenance treatment or follow-up may be considered after a response
• Which insurance plans the clinic works with and what authorisation may be required

Insurance arrangements vary by plan and provider. In Nebraska, insurers commonly seen include Blue Cross and Blue Shield of Nebraska, Medica, UnitedHealthcare, Aetna, Cigna and Heritage Health, Nebraska Medicaid. Coverage requirements, network status, clinical criteria and out-of-pocket costs should always be confirmed directly with the insurer and clinic.

Safety and realistic expectations

TMS is generally well tolerated. Common side effects include scalp discomfort during treatment and headache afterwards. These effects are often temporary. Seizure is a rare but recognised risk, which is one reason screening and clinician oversight are important.

An honest expectation is that TMS may offer a worthwhile chance of improvement, but no provider can promise response or remission. The best decision is usually one made after discussing the potential benefits, limitations, alternatives and practical commitments with a qualified clinician.

Getting help in Nebraska

Use the TMS Therapy Nebraska clinic listings to find the 11 published clinics in Omaha, Lincoln, Fremont, Bellevue, Lexington, Kearney and Blair. The directory’s insurance guide can help you prepare coverage questions, and the contact page can help you find further information.

This article is educational information, not medical advice.